Answers are grounded in this paper and cite their sources.
Chondrocyte differentiation governs skeletal formation, underpinning our understanding of human skeletal development and cartilage regenerative design. Existing human datasets are limited to early embryonic and late adult stages, leaving the critical post-conception week 9 to postnatal window poorly resolved. This gap obscures how compartmentalized osteochondral architectures are assembled from homogeneous mesenchymal condensates, and hinders digital predictive modeling of osteochondral biology and regeneration. Here, we comprehensively profiled human post-embryonic digits and identified prominent chondrocyte diversification from post-conception week 11 onwards. Integrating single-cell and spatial transcriptomics with in situ validation, we resolved osteochondral, perichondral, vascular, and hematopoietic subpopulations and characterized key transitional chondrocyte states, including naive, typical, hypertrophic, and fibrotic chondrocyte subsets. Our analyses revealed the emergence of COL2A1high chondrocyte subpopulations, their cell-cell crosstalk, and their bifurcated developmental trajectories toward articular-surface and bone fates respectively. We mapped the spatiotemporal patterns of crucial progenitor cell biomarkers within the niche, including gremlin1 (GREM1), proteoglycan 4 (PRG4), and periostin (POSTN). Moreover, a rare HLA-DRA high subpopulation was discovered. This subpopulation co-expressed chondrocyte markers and antigen-presenting cell signatures, representing a fundamental but undiscovered transitional state during cartilage-to-bone differentiation. We further demonstrated that our digital Post-Embryonic Chondrocyte Niche Atlas was a reliable reference for optimizing human cartilage organoid engineering. These advances have led to the identification of new transition states in chondrocyte developmental plasticity. In summary, these studies provide new fundamental knowledge for post-embryonic skeletal maturation, and a robust digital resource to advance chondrocyte-based research and future regenerative therapies.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: